MENU
IPSC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Century Therapeutics (IPSC) Ownership - Who owns Century Therapeutics?
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases... Show more
Profile
Industry
N/A
Address
25 N 38th Street
Phone
+1 267 817-5790
Employees
165
Web
https://www.centurytx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
45.48M
P/E Ratio
N/A
Total Cash
165.12M
Projected Growth
N/A
Total Debt
52.68M
Revenue
114.9M
Risk (Beta)
2.73
Dividend Yield
N/A
Total Cash/Share
1.92
Total Debt/Equity
N/A
Revenue/Share
1.36 USD as % of share price
Fundamentals
IPSC
Capitalization
45.5M
P/E Ratio
N/A
Risk (Beta)
2.73
Dividend Yield
N/A
Total Cash
165M
Total Cash/Share
1.92
Total Debt
52.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.36%
Revenue
115M
ROE
N/A
Book Value
240M
P/B Ratio
0.19
Cash Flow
N/A
Earnings
-0.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
11.70
Current Revenue Per Employee
661600.00
Dividends Per Share - Security
N/A
EBITDA
-5.99M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-6.61
Shares Held By Institutions
18.7M
Shares Outstanding - Current
86.2M
Total Liabilities
75.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
-47.337
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
25 N 38th Street
Phone
+1 267 817-5790
Employees
165
Web
https://www.centurytx.com